Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

35
Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT

Transcript of Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Page 1: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Dr. David Lyon

Clinical Governance Lead

Halton PCT

GP Affiliate NPDT

Page 2: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

The art of Medicine is to amuse the patient whilst nature cures the

disease

Voltaire

Page 3: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

TOP

BOTTOM

Page 4: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Repeated Use of the Cycle

Theories Testing changes Changes resulting in

improvement

A PS D

A PS D

Page 5: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

NSF Recommendations for Those with Established Disease

• Risk factors assessed, documented & advised, especially smoking.

• Medication: aspirin, beta blockers, ACEI

• Blood Pressure below 140/85

• Blood cholesterol lowered to less than 5mmol/l and LDL-C below 3mmol/l or by 30%

Page 6: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 7: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Getting the Ball Rolling• Disease Registers from medication & READ

coded entries• Additional Nurse Resource Devolved to Practices• Protocols for Nurse & for Referral to Secondary

Care• Computer Templates• Audit Team Geared up to Provide Rapid

Feedback

Page 8: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 9: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 10: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 11: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Advantages of Templates

• Quicker entry of standard data

• Consistent use of READ codes

• Display previous recordings

• Search for previous interventions

• Automatic calculations, e.g. BMI, risk score

• Clinician can be reminded of interventions

• Easier audit

Page 12: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 13: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% Population with IHD Runcorn

0

1

2

3

4

5

6

B C G H M T W ALL

1999200020012002

Page 14: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% Co-morbidity

0 10 20 30 40 50 60

Diabetes

Stroke/TIA

Hypertension

2002200120001999

Page 15: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% of patients with proven CHD on Aspirin First, Second, Third and Fourth Wave practices

50.0

55.0

60.0

65.0

70.0

75.0

80.0

85.0

90.0

95.0

100.0

Jul-00

Aug-00

Sep-00

Oct-00

Nov-00

Dec-00

Jan-01

Feb-01

Mar-01

Apr-01

May-01

Jun-01

Jul-01

Aug-01

Sep-01

Oct-01

Nov-01

Dec-01

Jan-02

Feb-02

Mar-02

Apr-02

May-02

Jun-02

Jul-02

Aug-02

Month

Per

cent

age

Series1 Series3 Series4 Series5

Page 16: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% of patients 1 year post-MI on Beta-BlockersFirst, Second,Third and Fourth Wave Practices

40.0

50.0

60.0

70.0

80.0

90.0

100.0

Jul-00

Aug-00

Sep-00

Oct-00

Nov-00

Dec-00

Jan-01

Feb-01

Mar-01

Apr-01

May-01

Jun-01

Jul-01

Aug-01

Sep-01

Oct-01

Nov-01

Dec-01

Jan-02

Feb-02

Mar-02

Apr-02

May-02

Jun-02

Jul-02

Aug-02

Month

Per

cent

age

Series1 Series3 Series4 Series5

Page 17: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% of patients with proven CHD on StatinsFirst, Second,Third and Fourth Wave practices

30.0

40.0

50.0

60.0

70.0

80.0

90.0

100.0

Jul-00

Aug-00

Sep-00

Oct-00

Nov-00

Dec-00

Jan-01

Feb-01

Mar-01

Apr-01

May-01

Jun-01

Jul-01

Aug-01

Sep-01

Oct-01

Nov-01

Dec-01

Jan-02

Feb-02

Mar-02

Apr-02

May-02

Jun-02

Jul-02

Aug-02

Month

Per

cent

age

Series1 Series3 Series4 Series5

Page 18: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

% of patients with proven CHD who have blood pressure below 140/85First, Second,Third and Fourth Wave practices

30.0

40.0

50.0

60.0

70.0

80.0

90.0

100.0

Jul-00

Aug-00

Sep-00

Oct-00

Nov-00

Dec-00

Jan-01

Feb-01

Mar-01

Apr-01

May-01

Jun-01

Jul-01

Aug-01

Sep-01

Oct-01

Nov-01

Dec-01

Jan-02

Feb-02

Mar-02

Apr-02

May-02

Jun-02

Jul-02

Aug-02

Month

Perc

enta

ge

Series1 Series3 Series4 Series5

Page 19: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 20: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 21: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Clinical Governance

• Protected Time for Regular Team Meetings

• Significant EventsPremature DeathsNew Cancer CasesUnpleasantness In The Waiting Room

• Summaries to Clinical Governance Team

• SEA News

Page 22: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 23: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 24: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

What Happened

• Focus on the facts

• No blame

• It’s the system

• What went well

• What was OK

• What could have gone better

• What should we do next time?

Page 25: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Acute Chest Pain Protocol

• Is the patient alert?

• Is the patient’s breathing normal?

• Is the pain severe?

• Is there heart problems or diabetes?

• Is it heavy, crushing, pressure or tight?

• Is there nausea or vomiting?

• Is the patient sweating or clammy?

Page 26: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Acute Chest Pain Protocol

• 51 cases in 12 months

• 10 (19%) MI 1 had VF within 5 minutes

• 7 (14%) crescendo angina

• 24 (47%) admitted to rule out MI

• 8 (16%) had blood test etc. & discharged

• 2 (4%) dysrhythmia

• Call to needle time less than 60 minutes

Page 27: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.
Page 28: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Cardiac Events Castlefields Health Centre

0

10

20

30

40

50

60

92/93 93/94 94/95 95/96 96/97 97/98 98/99 99/00 00/01 '01/02

IHD Deaths Non-fatal Mis

Page 29: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Cardiac Events per Thousand

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

Non-fatal MI Acute CHD Death

1999200020012002

Page 30: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

DEATHS

• Practice records

• ONS (Office of National Statistics)

• Public Health

• 3 Character Postcodes

• Trend over Time

• Twelve Month Periods

Page 31: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Percentage Improvement In CHD Deaths All Ages For First Twelve Months Of Waves 1 And 2

-30

-25

-20

-15

-10

-5

0

5

10

15

20

25

%

Page 32: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Percentage Improvement In CHD Deaths All AgesOver Twelve Months

0

1

2

3

4

5

6

7

8

9

England Wave 1 Wave 2

%

Page 33: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

At Risk

• Other Athersclerotic Disease

• Diabetes

• Hypertension

• Heart Failure

• Middle-aged men

• Strong Family History

• Smoking, Post-menopausal women

Page 34: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.

Essential Ingredients

• Clear evidence and Clear focus• Examples From The Field• Time to consider solutions• Reality of working at ‘street level’• Systematic recording of information• Rapid feedback• Appropriate resources• Skilled management

Page 35: Dr. David Lyon Clinical Governance Lead Halton PCT GP Affiliate NPDT.